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Background
Tuberculous meningitis (TBM) is a growing problem in
HIV-infected patients. Our objectives were to analyze
the main clinical and laboratory features and immuno-
virological particularities and outcomes of HIV-infected
individuals with TBM.
Methods
We performed a retrospective study of HIV-infected
patients admitted for TBM to the Hospital of Infectious
Diseases Iaşi in the last 10 years.
Results
We registered 21 cases (median age 23, 47% male), out
of which 47% had pulmonary TB previously. Clinical
features were: abrupt onset 57%, headache 47%, fever
66%, vomiting 38%, respiratory symptoms 38%, coma
9.5%, cranial nerve palsy 19%, meningeal syndrome 38%,
altered level of consciousness 19%. Laboratory findings
of cerebrospinal fluid: clear aspect 81%, pleocytosis less
than 500/cmm 66%, protein level more than 1 g/L 91%,
glucose level less than 0.4 g/L 71%, decreased chlorine
level 57%. Radiologically we found adenopathy in the
pulmonary hilum in 24% of patients. Neurological com-
plications occurred in 24% and drug related liver toxicity
in 33%. We identified 47% of HIV-infected persons dur-
ing 1987-1990. The interval between the diagnosis of the
HIV-infection and the present hospital admission had a
median of 6 years. The median value of the actual CD4
count was 92/cmm and viral load 570,000 copies/mL.
Prior antiretroviral therapy (ART) was administered in
80% of patients with a median of 4 regimens. Only 19%
of the patients were classified as adherent to the ART.
The antiretroviral therapy administrated during the pre-
sent hospital admission was: AZT/3TC + EFV – 9.5%,
ABC/3TC + EFV – 9.5%, ABC/3TC + KLT – 4.7%,
ABC + RAL + T20 – 4.7%. The median period of hospi-
talization was 10 days. The overall mortality during
hospitalization was 43% and at 9 months it was 29%. The
9-month survival rate was 28%.
Conclusion
Immunological and virological failure generated by non-
adherence favored the occurrence of TBM. Although the
CNS penetration-effectiveness score of the current antire-
troviral regimen was above 8, this did not influence the
mortality rate in neuro-meningeal tuberculous infection.
In HIV-associated TBM, the clinical course and dismal
outcome are undoubtedly influenced by the profound
immunosuppression at presentation, emphasizing the
need for earlier diagnosis of the HIV infection and initia-
tion of antiretroviral treatment.
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